Predicting Efficacy of Restenosis Therapies Using Cell Cultures
Author Information
Author(s): Hila Epstein, Laura Rabinovich, Shmuel Banai, Vicktoria Elazar, Jianchuan Gao, Michael Chorny, Haim D. Danenberg, Gershon Golomb
Primary Institution: The Hebrew University of Jerusalem
Hypothesis
Can cell culture studies of both free drug and drug embedded in a polymer predict the results obtained in animal in vivo studies?
Conclusion
The study suggests that cell culture studies can help predict the effectiveness of drugs for restenosis therapy, but results vary by species.
Supporting Evidence
- The study found that porcine smooth muscle cells were the most proliferative, while human cells were the least.
- Heparin was effective in inhibiting smooth muscle cell proliferation in animal models but not in human-derived cells.
- Different species showed varying sensitivity to the drugs tested, indicating that results from animal studies may not directly translate to humans.
Takeaway
Scientists are trying to figure out if testing drugs in cells can tell us how well they will work in real animals. Different animals react differently to the same drugs.
Methodology
The study used arterial explant outgrowth models and smooth muscle cell cultures from different species to evaluate drug efficacy.
Limitations
The validity of in vitro culture studies for screening controlled release delivery systems such as nanoparticles is limited.
Participant Demographics
The study involved smooth muscle cells from rats, rabbits, pigs, and humans.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website